Johnson & Johnson Covid-19 vaccine enters Phase 3 trial in U.S.
0
The drugmaker's vaccine candidate is the fourth to enter final-phase human trials in the country.
The drugmaker's vaccine candidate is the fourth to enter final-phase human trials in the country.